These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact opposite direction. Medical device specialist (NASDAQ: DXCM) and social media platform Pinterest (NYSE: PINS) are in the latter group.
Both failed to impress investors with their second-quarter results. DexCom's stock dropped by about 40% in one day, while Pinterest's declined by a little over 15%. Was this an overreaction by the market? Are these companies worth investing in on the dip? Let's find out.
DexCom is a leader in the continuous glucose monitoring (CGM) market. CGM devices allow diabetes patients to keep track of their blood sugar levels. The medical device giant's newest product, the G7, hit the U.S. market last year. The continued adoption of DexCom's devices, including the new G7, has been a massive growth driver for the company.
Source Fool.com
Dexcom Inc. Aktie
Klare Kaufempfehlung: Dexcom Inc. erhält nur Buy-Einschätzungen.
Eine Steigerung von über 50% ist für Dexcom Inc. möglich, angesichts eines Kursziels von 121 € gegenüber 62.25 €.
